GSKCONS Charts, Analysis and Tips

home > trading-and-exports > gskcons

Technical Analysis

Technical Strength: 5.5 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 51.7. According to RSI analysis, gskcons is marginally weak. 4.0 GSKCONS RSI Chart
MACD (?) MACD: -0.445 and Signal Line: -4.22. According to MACD analysis, gskcons is marginally strong. 7.0 GSKCONS MACD Chart
Simple Moving Average (?) 20-day simple moving average just got below it's 50-day simple moving average which is a negative signal. According to simple moving average analysis, gskcons is facing resistance from it's 200-day simple moving average at 5608.335 and support level is at 5.21e+03. 4.0 GSKCONS Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, gskcons is facing resistance from it's 200-day exponential moving average at 5456.793 and support level is at 5.23e+03. 7.0 GSKCONS Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.673. 5.0 GSKCONS Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above 61.8% level. Support is at 5229.2829 Resistance levels are 5295.475 and 5361.6671. 6.5 GSKCONS Fibonacci Retracement Chart
Average True Range (?) ATR: 104 NA GSKCONS Average True Range Chart
Average Directional Index (?) ADX is 19.6 which means GSKCONS is in a trading range and there is no trend. NA GSKCONS Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
April 21, 2017
Open Price 5240.35
High Price 5295.0
Low Price 5226.15
Close Price 5248.1
Absolute Change -17.35
Percentage Change -0.33%
Weekly Change -0.952%
Monthly Change -3.47%
Yearly Change -12.9%
52-week high 6600.0
52-week low 4708.0
Corporate Actions
ExDate Purpose
July 26, 2016 AGM/DIV-RS 70 PER SHARE
July 27, 2015 AGM/DIV-RS 55 PER SHARE
July 28, 2014 AGM/DIV-RS 45 PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.348
Confidence in Beta1.76%
Market Capital Rs. 22071.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. 163.32
TTM Price-to-Earnings (P/E) Ratio 32.1
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 21 April 2017: Deliverable Quantity:1.5e+03 NA GSKCONS Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 21 April 2017: Daily Volatility:0.2121 NA GSKCONS Annualized Daily Volatility (Spot Price) Chart


April 11, 2017 GlaDisc. under Reg.30 of SEBI (SAST) Reg.2011axoSmithKline Pte Ltd has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
March 20, 2017 GlaTrading WindowaxoSmithKline Consumer Healthcare Limited has informed the Exchange that In accordance with the Company's Policy on Insider Trading, the date of commencement of closing of Trading Window shall be from March 21, 2017 and shall end 48 hours after public announcement of the Audited / Un-Audited Financial Results for the Financial Year 2016-17.
See all Announcements

Board Meetings

Date Meeting Date Purpose
March 14, 2017 March 22, 2017 to Others discuss future strategies of the Company.
February 01, 2017 February 13, 2017 To,Results, inter alia, consider and take on record the Unaudited Financial Results of the Company for the quarter ended December 31, 2016 with Limited Review by Statutory Auditors.
See all Board Meetings

GSKCONS is part of...

Index Weightage

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 5149 Rs. 5188 Rs. 5218 Rs. 5256 Rs. 5287 Rs. 5325 Rs. 5356